EVOGENE LTDNARY SHARES
EVOGENE LTDNARY SHARES
Acción · IL0011050551 · EVGN (XNAS)
Resumen Indicadores financieros
1,39 USD
-4,79 % -0,07 USD
NASDAQ (XNAS) · Precios actuales y gráficos en MoneyPeak
13.06.2025 20:43

Cotizaciones actuales de EVOGENE LTDNARY SHARES

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
EVGN
USD
13.06.2025 20:43
1,39 USD
1,53 USD
-9,15 %

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
-4,79 % 26,36 % 23,01 % -2,11 % 4,51 % -78,95 % -86,37 %

Perfil de la empresa para EVOGENE LTDNARY SHARES Acción

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

Datos de la empresa

Nombre EVOGENE LTDNARY SHARES
Empresa Evogene Ltd.
Símbolo EVGN
Sitio web https://www.evogene.com
Mercado principal XNAS NASDAQ
ISIN IL0011050551
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Mr. Ofer Haviv CPA
País Israel
Moneda USD
Empleados 0,1 T
Dirección 13 Gad Feinstein Street, 7414002 Rehovot
Fecha de OPV 2010-10-15

Splits de acciones

Fecha Split
25.07.2024 1:10
19.11.2013 1:2

Símbolos de cotización

Nombre Símbolo
NASDAQ EVGN

Otras acciones

Los inversores que tienen EVOGENE LTDNARY SHARES también tienen las siguientes acciones en su cartera:
AMERN TOWER 19/49
AMERN TOWER 19/49 Bono
COMM.EDISON 20/30
COMM.EDISON 20/30 Bono
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025